Global Financial Private Client, LLC Biomarin Pharmaceutical Inc Transaction History
Global Financial Private Client, LLC
- $262 Billion
- Q1 2025
A detailed history of Global Financial Private Client, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Global Financial Private Client, LLC holds 28 shares of BMRN stock, worth $1,722. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28
Previous 12
133.33%
Holding current value
$1,722
Previous $789,000
150.82%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BMRN
# of Institutions
634Shares Held
184MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.4 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.19 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.12 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$907 Million0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$799 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.4B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...